N
CAMP icon

Nuveen’s CAMP4 Therapeutics CAMP Stock Holding History

Nuveen’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$184K Buy
+42,048
New +$181K ﹤0.01% 3658

Other funds holding CAMP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Nuveen's CAMP Position: Q2 2026 in Review

Nuveen opened a new position in CAMP4 Therapeutics (CAMP) in Q2 2026: 42,048 shares worth $184K. The stake represents ﹤0.01% of the portfolio and ranks #3658 among its holdings.

18 funds tracked by Wall St. Rank hold CAMP as of Q2 2026.

  • Nuveen held 42,048 shares of CAMP4 Therapeutics worth $184K as of Q2 2026.
  • CAMP4 Therapeutics was a new Nuveen position in Q2 2026.
  • CAMP4 Therapeutics made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #3658 holding.
  • 18 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.